These results indicate that SLC34A1 could reflect the state of the ccRCC immune microenvironment and could be a potential diagnostic and predictive biomarker, as well as a treatment option for ccRCC. The gene discussed is SLC34A1; the disease is nonpapillary renal cell carcinoma.